These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1731782)

  • 1. The effects of novel cathepsin E inhibitors on the big endothelin pressor response in conscious rats.
    Bird JE; Waldron TL; Little DK; Asaad MM; Dorso CR; DiDonato G; Norman JA
    Biochem Biophys Res Commun; 1992 Jan; 182(1):224-31. PubMed ID: 1731782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoramidon blocks the pressor activity of big endothelin[1-39] and lowers blood pressure in spontaneously hypertensive rats.
    McMahon EG; Palomo MA; Moore WM
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S29-33. PubMed ID: 1725358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro.
    McMahon EG; Palomo MA; Moore WM; McDonald JF; Stern MK
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):703-7. PubMed ID: 1992461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoramidon inhibits the conversion of big ET-1 into ET-1 in the pithed rat and in isolated perfused rat kidneys.
    Verbeuren TJ; Mennecier P; Merceron D; Simonet S; de Nanteuil G; Vincent M; Laubie M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S81-4. PubMed ID: 7510006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
    Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic processing of porcine big endothelin-1 catalyzed by cathepsin D.
    Takaoka M; Hukumori Y; Shiragami K; Ikegawa R; Matsumura Y; Morimoto S
    Biochem Biophys Res Commun; 1990 Dec; 173(3):1218-23. PubMed ID: 2268325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of endothelins and big endothelins in ketamine/xylazine or urethane anesthetized rats.
    Gratton JP; Maurice MC; Rae GA; D'Orléans-Juste P
    Am J Hypertens; 1995 Nov; 8(11):1121-7. PubMed ID: 8554736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of big ET-1 in the rat lung: role of phosphoramidon-sensitive endothelin-1-converting enzyme.
    Hisaki K; Matsumura Y; Maekawa H; Fujita K; Takaoka M; Morimoto S
    Am J Physiol; 1994 Feb; 266(2 Pt 2):H422-8. PubMed ID: 8141343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characterization of a phosphoramidon-sensitive endothelin-converting enzyme in the rat.
    Pollock DM; Divish BJ; Milicic I; Novosad EI; Burres NS; Opgenorth TJ
    Eur J Pharmacol; 1993 Feb; 231(3):459-64. PubMed ID: 8449237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode of cleavage of porcine big endothelin-1 by aspartic proteinases.
    Takaoka M; Hukumori Y; Shiragami K; Ikegawa R; Matsumura Y; Morimoto S
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S68-70. PubMed ID: 1725436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential pharmacological profile of endothelin-1 and its precursor, big endothelin.
    Le Monnier de Gouville AC; Cavero I
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S362-5. PubMed ID: 1725381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized rats.
    Matsumura Y; Fujita K; Takaoka M; Morimoto S
    Eur J Pharmacol; 1993 Jan; 230(1):89-93. PubMed ID: 8094056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The conformation of human big endothelin-1 favours endopeptidase hydrolysis of the TRP21-VAL22 bond.
    Corder R
    Biochem Pharmacol; 1996 Feb; 51(3):259-66. PubMed ID: 8573192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cardiovascular and neural activity of endothelin-1, -2, -3 and respective proendothelins: effects of phosphoramidon and thiorphan.
    Mattera GG; Eglezos A; Renzetti AR; Mizrahi J
    Br J Pharmacol; 1993 Sep; 110(1):331-7. PubMed ID: 8106108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme.
    Pollock DM; Shiosaki K; Sullivan GM; Opgenorth TJ
    Biochem Biophys Res Commun; 1992 Jul; 186(2):1146-50. PubMed ID: 1497648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.
    Lebel N; D'Orléans-Juste P; Fournier A; Sirois P
    Br J Pharmacol; 1996 Jan; 117(1):184-8. PubMed ID: 8825361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrarenal conversion of big endothelin-1 to endothelin-1 in the rat.
    Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
    Life Sci; 1994; 55(16):1285-91. PubMed ID: 7934630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay evidence that the pressor effect of big endothelin-1 is due to local conversion to endothelin-1.
    Corder R; Vane JR
    Biochem Pharmacol; 1995 Jan; 49(3):375-80. PubMed ID: 7857324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.